Advances in Biological Therapies for Atopic Dermatitis in Adults and Children

Complimentary

Released on 12/10/21
Expires on 12/10/22

Categories: , , , , , , , , , , , ,
Close-up of a leg with a red, irritated, scaly rash.

Start Activity

Program Description

This activity is designed to address the knowledge and practice gaps of dermatologists, allergists, primary care physicians, nurse practitioners, physician assistants, and nurses involved in the care and treatment of moderate-to-severe patients atopic dermatitis (AD). The faculty will discuss pathophysiology and the latest data and give real-world examples and recommendations for moderate-to-severe AD treatment. Focusing on novel therapies, the activity will highlight systemic AD treatment options, including indications, efficacy, and safety of the currently available and emerging agents. Challenges encountered in the treatment of AD will also be highlighted.

Intended Audience

This webcast is designed to meet the educational needs of dermatologists, allergists, primary care physicians, nurse practitioners, physician assistants, and nurses involved in the diagnosis and treatment of atopic dermatitis in adults and children.

Commercial Supporter

This activity is supported by an educational grant from Leo Pharma Inc.

Educational Objectives

Upon completion of the educational activity, participants should be able to:

  • Appraise the differential diagnosis of rashes that share the common characteristic of mild, moderate, and severe AD to guide treatment and referral strategies
  • Select optimal strategy and compare the efficacy and safety of interleukin (IL)-4, IL-13, IL-31 mAbs in adult and pediatric patients with AD

Accredited Providers

Jointly provided by Amedco, a CME/CE company, and MedNet, LLC

      

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and MedNet, LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians (ACCME) Credit Designation

Designation Statement

Amedco LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) Credit Designation

Designation Statement

Amedco LLC designates this enduring material activity for a maximum of 1.0 ANCC contact hours.

Additional Credit Information

Note to Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum of 1.0 hours.

Note to Physician Assistants
AAPA accepts AMA PRA Category 1 Credit(s)TM for the PRA from organizations accredited by ACCME. Maximum of 1.0 hours.

Planners and Managers Disclosures

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:

Kamatham A. Naidu, PhD (MedNet) has no relevant financial relationships to disclose.
Brian Waggoner (MedNet, LLC) has no relevant financial relationships to disclose.
Sheryl Morgan (Amedco) has no relevant financial relationships to disclose.

Conflicts of Interest Policy

It is the policy of the Amedco to ensure activity content is balanced, independent, objective and based on scientific best-evidence. All persons in a position to control content (i.e., course director, planning committee member and speaker) were required to disclose any relevant financial relationship with a commercial entity relative to the content of his/her presentation.

Every person in a position to control content reported he/she does not have any relevant financial relationships with industry (relative to the content of his/her presentation) to disclose.

Disclosure of Unlabeled Use

It is the policy of the Amedco to inform each speaker of his/her responsibility to disclose to the attendees when products or procedures discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved) and of any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.

Each speaker reported he/she will notify the audience if/when discussion includes off-label, unlabeled, experimental, and/or investigational (not FDA approved) information or limited use references within the content of his/her presentation.

Disclaimer

The information provided at this educational initiative is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Non-Endorsement of Products

Amedco do not imply either real or implied endorsement of any product, service, or company referred to in this educational activity.

Faculty

Peter A. Lio, MD
Department of Dermatology
Feinberg School of Medicine
Northwestern University
Chicago, IL

Dr. Lio discloses that he received Research Grants/Funding from Regeneron/Sanofi Genzyme, AOBiome, and Abbvie; served on the speaker’s bureau: Regeneron/Sanofi Genzyme, Eli Lilly, Pfizer, and Galderma; and was a consultant and on the advisory boards of Dermavant, Regeneron/Sanofi Genzyme, Dermira, Pfizer, LEO Pharmaceuticals, Abbvie, Eli Lilly, Galderma, and IntraDerm.

Instructions

There are no fees for participating and receiving CME/CE credit for this webcast. During the period from December 10, 2021, through December 10, 2022, participants must read all the material and study the educational webcast.

This webcast includes text, graphics, and may include multimedia features.

To obtain credit, a score of 75% or better on the post-assessment is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-assessment and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Dashboard or Transcript, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact the CME/CE Provider at certificate@amedcoemail.com.

If you have any other questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

Amedco observes privacy and confidentiality of CME/CE information and personal information of CME/CE participants. Third parties receive only aggregated data about CME/CE activities that are relevant to their interests and/or the activities they support.

myCME privacy policy

Webcast

Time to Complete: 1 hour

Released: December 10, 2021

Expires: December 10, 2022

Maximum Credits:
1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE Contact Hour

Related products